WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (Nasdaq: NURO) announced that Frank McGillin, Senior
Vice President and General Manager, Consumer will participate in a panel
discussion entitled "The Rise of Enterprise & Condition-Specific
Wearables" during the Fifth Annual Digital Health Summer Summit. Digital
Health is co-located with the 2016 Bio International Convention at the
Moscone Center in San Francisco and the panel discussion will be held on
Tuesday, June 7 at 11:15am (Pacific).
Mr. McGillin will join other industry leaders including moderator Chris
Bergstrom, Associate Director - Digital Health, BCG; Rich Buchler
Co-Founder and CEO, VIZR Tech; Ben Hwang, CEO, Profusa; and Ashwin
Pushpala, CEO, Sano Intelligence Inc.
"The theme of the Digital Health Summit event is Igniting the
Tipping Point," said Mr. McGillin, "The fact that digital health is
also a track at BIO 2016 is a good indication that the time is right for
innovative technology that addresses the burden of chronic disease.
Products like Quell® are an example of what is possible in a
sophisticated connected consumer health device."
The Fifth Annual Digital Health Summer Summit at BIO 2016 takes a deep
dive into the elements of a successful digital health venture and
showcases the latest digital health innovations from the industry's
leaders and organizations who will explore the issues and opportunities
facing the industry.
About Quell
Quell utilizes NeuroMetrix's patented neurostimulation technology to
provide widespread relief from chronic pain. The advanced wearable
device is lightweight and can be worn during the day while active, and
at night while sleeping. It has been cleared by the FDA for treatment of
chronic pain without a prescription. In a recent study, 81% of Quell
users reported an improvement in their chronic pain. Quell includes a
smartphone app that tracks and personalizes their pain therapy. It is
available for purchase at QuellRelief.com, selected retailers and
healthcare professionals.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160518005185/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
